Intrinsic Value of S&P & Nasdaq Contact Us

Star Equity Holdings, Inc. STRR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
-16.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Star Equity Holdings, Inc. (STRR) has a negative trailing P/E of -6.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 11.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -15.45%, forward earnings yield 8.48%. PEG 5.61.

Criteria proven by this page:

  • VALUE (20/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -6.5); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -15.45%); analyst consensus target implies downside from the current price ($8.00, 16.8%); PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 5.61).
  • Forward P/E 11.8 — analysts expect a return to profitability with estimated EPS of $0.82 for FY2026.
  • PEG Ratio 5.61 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -15.45% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 8.48% as earnings recover.
  • Analyst consensus target $8.00 (-16.8% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
48/100
SG Score
View full scorecard →
VALUE
20/100
Price-to-Earnings & upside
Proven by this page
FUTURE
28/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
51/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — STRR

Valuation Multiples
P/E (TTM)-6.5
Forward P/E11.8
PEG Ratio5.61
Forward PEG5.61
P/B Ratio0.53
P/S Ratio0.24
EV/EBITDA-22.8
Per Share Data
EPS (TTM)$-1.51
Forward EPS (Est.)$0.82
Book Value / Share$18.55
Revenue / Share$43.24
FCF / Share$-2.96
Yields & Fair Value
Earnings Yield-15.45%
Forward Earnings Yield8.48%
Dividend Yield0.00%
Analyst Target$8.00 (-16.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 1.9 -0.05 0.40 0.21 14.68%
2017 -1.3 0.01 1.62 0.38 9.32%
2018 37.0 -0.37 1.05 0.26 12.20%
2019 -5.3 0.00 0.60 0.33 -
2020 -6.0 0.56 0.96 0.49 -
2021 -49.4 0.85 3.75 1.38 3.00%
2022 -17.8 -0.55 2.04 0.83 2.05%
2023 29.1 -2.31 1.32 0.40 3.00%
2024 -3.9 -0.02 1.02 0.77 4.97%
2025 -6.1 0.13 0.55 0.21 2.06%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $7.10 $125.47M $14.3M 11.4%
2017 $-17.87 $118.34M $-35.73M -30.2%
2018 $0.37 $104.18M $736K 0.7%
2019 $-2.40 $114.19M $-4.89M -4.3%
2020 $-1.44 $78.16M $-5.29M -6.8%
2021 $-1.76 $106.56M $-8.93M -8.4%
2022 $-0.36 $112.15M $-5.25M -4.7%
2023 $7.36 $45.79M $25.13M 54.9%
2024 $-3.97 $53.36M $-10.44M -19.6%
2025 $-2.08 $172.16M $-5.92M -3.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.82 $0.60 – $0.99 $237.57M $232.04M – $240.64M 2
2027 $1.30 $1.10 – $1.41 $251.23M $242M – $265M 2
2028 $0.85 $0.82 – $0.89 $234.67M $227.58M – $242.77M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message